Endo USA Inc., a Keenova Therapeutics Company
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Endo USA Inc., a Keenova Therapeutics Company sits in the top decile of US sponsors by registered trial count (#334 of 15,751 sponsors by registered trial count).
Endo USA Inc., a Keenova Therapeutics Company: 61 sponsored US clinical trials, none currently recruiting.
Endo USA Inc., a Keenova Therapeutics Company sponsors 61 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 46 completed. 29 of these trials are in Phase 3-4 (later-stage) and 23 in Phase 1-2 (earlier-stage).
Top-decile sponsor footprint
Endo USA Inc., a Keenova Therapeutics Company ranks in the top decile of sponsors by registered trial count (#334 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Indexed trials (enrollment closed)
61 total, page 2 of 2
Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual Migraine
NCT00904098
EXPRESS: Examining Pagoclone for Persistent Developmental Stuttering Study
NCT00216255
Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
NCT00637572
Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain
NCT00225797
Pilot Study of Lidocaine 5% Patch Versus Placebo in Patients With Osteoarthritis Pain of the Knee
NCT00904462
A Study Comparing The Efficacy And Safety Of Lidocaine 5% Patch With Placebo In Patients With Chronic Axial Low Back Pain
NCT00904111
Lidocaine Patch 5% Versus Celecoxib 200 mg in Chronic Axial Low Back Pain
NCT00904397
Lidocaine Patch Versus Celecoxib in Pain From Osteoarthritis of the Knee
NCT00904605
A Study of the Effectiveness And Safety Of Lidoderm® As Add-On Treatment in Patients With Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back Pain
NCT00904020
A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual Migraine
NCT00644033
Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy
NCT00904280
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 19 |
| Phase 3 | 22 |
| Phase 4 | 7 |
How the Endo USA Inc., a Keenova Therapeutics Company archive is shaped
61 indexed studies, none listed as recruiting (0% open); 46 completed (75%).
Phase mix: 29 late (III/IV) vs 23 early (I/II) (balanced across stages).
Therapeutic area indexing for this sponsor is limited in the public registry.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.